FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Famotidine Injection
Status: Currently in Shortage
»Date first posted: 05/05/2020
»Therapeutic Categories: Gastroenterology

Expand all

Baxter Healthcare (New 05/05/2020)

Company Contact Information:
888-229-0001

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Famotidine Injection premix, 20mg/50 mL in GALAXY Plastic Container (NDC 0338-5197-41) Available – backorders due to high demand. Recovery expected Q3 2020. Demand increase for the drug

Fresenius Kabi USA, LLC (Reverified 05/19/2020)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
20 mg per 2 mL (10 mg per mL), single dose vial, PF, (NDC 63323-739-12) Available Check wholesalers for inventory Demand increase for the drug
40 mg per 4 mL (10 mg per mL), mutilple dose vial, (NDC 63323-738-09) Backordered. Next release May 2020. Demand increase for the drug
200 mg per 20 mL(10 mg per mL), multiple dose vial, (NDC 63323-738-20) Backordered. Next release May 2020. Demand increase for the drug

Hikma Pharmaceuticals USA, Inc. (formerly West-Ward) (Revised 05/12/2020)

Company Contact Information:
800-631-2174

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
10 mg/mL, 2 mL vial (NDC 0641-6022-25) This presentation is temporarily on backorder. Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released. Demand increase for the drug
10 mg/mL, 4 mL vial (NDC 0641-6023-25) This presentation is temporarily on backorder. Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released. Demand increase for the drug
10 mg/mL, 20 mL vial (NDC 0641-6021-10) This presentation is temporarily on backorder. Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released. Demand increase for the drug

Mylan Institutional (New 05/06/2020)

Company Contact Information:
800-796-9526

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Famotidine Injection (Solution in Single Dose Vials) [20 mg / 2 ml] 25PK (NDC 67457-433-22) Intermittent supply until the middle of June 2020 Demand increase for the drug
Famotidine Injection (Solution in Multi Dose Vials : Containing Preservatives) [40 mg / 4 ml] 10PK (NDC 67457-448-43) Currently available with intermittent supply until the middle of June 2020 Demand increase for the drug
Famotidine Injection (Solution in Multi Dose Vials : Containing Preservatives) [200 mg / 20 ml] 10PK (NDC 67457-457-20) Intermittent supply until the middle of June 2020 Demand increase for the drug

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English